VCP Scanner
ScreenerTechnicalBreakoutsThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistPricing
ScreenerTechnical ScannerBreakoutsThemes
Earnings
WatchlistPricing
Ctrl K
HLN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
HLNHaleon plc
$10.03$44.7B
Overview & Verdict
OverviewVisualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksHLNBalance Sheet

Haleon plc (HLN) Balance Sheet

7Y historyFree accessUpdated daily

Debt-to-equity improved to 0.50 with total debt at $8.2B, but goodwill of $25.6B (79% of assets) and a thin current ratio of 0.69 indicate impairment and liquidity risks.

HLN Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19
Total Current Assets4.27B4.54B5.72B4.82B4.06B5.25B5.01B5.81B
Cash & Short-Term Investments821.01M1.32B2.25B1.04B684M414M334M340M
Cash Only821.01M1.32B2.19B1.04B684M414M334M340M
Short-Term Investments0055M00000
Accounts Receivable2.33B2.12B1.9B1.35B1.49B3.83B1.35B3.99B
Days Sales Outstanding34.9870.1361.8743.6649.99146.2749.74171.91
Inventory1.06B1.02B1.19B1.41B1.35B951M949M1.21B
Days Inventory Outstanding50.7397.46101.37118.39114.9396.5586.99120.18
Other Current Assets45.72M77.86M223M907M434M5M2.32B237M
Total Non-Current Assets28.12B28.03B28.6B29.24B30.76B29.2B29.12B29.9B
Property, Plant & Equipment2.05B1.99B1.92B1.9B1.9B1.66B1.6B1.62B
Fixed Asset Turnover11.33x5.53x5.85x5.94x5.72x5.74x6.17x5.23x
Goodwill08.13B8.2B8.32B8.4B8.25B8.27B8.17B
Intangible Assets25.59B17.49B18.01B18.54B20.04B18.95B18.95B19.84B
Long-Term Investments294.4M75.87M82M65M44M23M03M
Other Non-Current Assets123.25M104.82M383M415M157M8M51M10M
Total Assets32.38B32.57B34.31B34.05B34.81B34.45B34.13B35.71B
Asset Turnover0.68x0.34x0.33x0.33x0.31x0.28x0.29x0.24x
Asset Growth %-7.26%-5.08%0.76%-2.18%1.06%0.94%-4.43%-
Total Current Liabilities6.21B4.92B5.81B4.64B4.37B4.24B4.01B4.27B
Accounts Payable3.77B3.72B1.97B1.85B1.83B1.58B1.83B1.9B
Days Payables Outstanding149.97354.65168.06155.97156.45160.32167.47188.36
Short-Term Debt1.95B834.53M1.44B608M393M874M348M481M
Deferred Revenue (Current)33.94M33.94M0023M11M11M7M
Other Current Liabilities219.67M17.88M693M1.57B1.61B1.43B958M913M
Current Ratio0.69x0.92x0.98x1.04x0.93x1.24x1.25x1.36x
Quick Ratio0.52x0.71x0.78x0.73x0.62x1.01x1.01x1.08x
Cash Conversion Cycle-64.27-187.06-4.836.088.4682.51-30.74103.73
Total Non-Current Liabilities9.84B11.19B12.28B12.69B13.99B3.73B3.89B4.03B
Long-Term Debt6.14B7.66B8.54B8.71B9.89B1M00
Capital Lease Obligations355.33M85M73M89M117M87M105M121M
Deferred Tax Liabilities13.04B3.22B3.35B3.49B3.6B3.36B03.51B
Other Non-Current Liabilities316.08M217.62M311M424M384M289M3.79B0
Total Liabilities16.04B16.12B18.09B17.33B18.36B7.97B7.91B8.3B
Total Debt8.2B8.59B10.1B9.46B10.44B991M487M642M
Net Debt7.38B7.27B7.91B8.41B9.76B577M153M302M
Debt / Equity0.50x0.52x0.62x0.57x0.63x0.04x0.02x0.02x
Debt / EBITDA1.50x3.11x4.21x4.10x4.94x0.52x0.26x0.55x
Net Debt / EBITDA1.35x2.63x3.29x3.65x4.62x0.30x0.08x0.26x
Interest Coverage7.70x7.60x5.88x4.93x5.46x121.44x62.62x32.49x
Total Equity16.34B16.46B16.22B16.73B16.46B26.48B26.22B27.41B
Equity Growth %-3.7%1.42%-3.02%1.65%-37.85%0.98%-4.34%-
Book Value per Share3.663.653.543.613.565.735.685.94
Total Shareholders' Equity16.28B16.4B16.17B16.61B16.33B26.36B26.11B27.32B
Common Stock87.47M89.84M91M92M92M1M1M1M
Retained Earnings27.52B16.13B27.27B27.47B26.73B37.99B37.76B5.11B
Treasury Stock0-160.72M-116M00000
Accumulated OCI-11.33B335.41M761.46M-10.96B1.2B-11.63B-11.65B1.37B
Minority Interest59.64M58.9M58M123M126M125M111M91M

Key Metrics

Growth RegimeStable
ProfitabilityStrong
Balance SheetAdequate
Cash FlowStable
Top Statement Risk

Regulatory and shareholder overhang

Leverage Drift and Asset Base Stability

Haleon's total assets have contracted from $34.8B in 2022Q4 to $32.4B in 2026Q2, while debt-to-equity eased from 0.63 to 0.50, according to recent balance sheet data, indicating a deleveraging trend.

The reduction in total assets is primarily driven by a decline in goodwill from $28.5B in 2022Q2 to $25.6B in 2026Q2, reflecting divestitures and potential impairments. The balance sheet appears to be stabilizing as leverage metrics improve, but the asset base contraction suggests a portfolio reshaping that may limit future growth capacity. Investors should monitor whether this deleveraging is sustainable without sacrificing investment in core brands.

Debt Reduction Tempered by Cash Volatility

Total debt fell from $10.4B in 2022Q4 to $8.2B in 2026Q2, with D/E improving to 0.50, as per reported figures, but cash reserves remain thin at $821M, suggesting limited liquidity buffer.

The consistent reduction in absolute debt indicates a strategic focus on deleveraging, likely to regain investment-grade flexibility. However, the current ratio of 0.69 in 2026Q2 is below 1.0, implying potential short-term liquidity strain if cash flows weaken. The low cash balance relative to debt suggests that refinancing risk is manageable but warrants monitoring, especially given the seasonal nature of working capital.

Goodwill Dominance Masks Tangible Asset Base

Goodwill and intangibles constitute approximately 79% of total assets in 2026Q2, based on balance sheet data, while net PPE is only $2.0B, indicating an asset-light model with significant impairment risk.

The heavy reliance on goodwill from the demerger exposes the balance sheet to potential write-downs if brand performance falters. The modest PPE suggests low capital intensity, consistent with a consumer health model, but the concentration in intangibles means that any adverse regulatory or competitive developments could trigger impairments. The stability of PPE over time indicates limited reinvestment, which may be appropriate given the low capex requirements.

Retained Earnings Growth Underpins Equity

Equity remained stable around $16.3B in 2026Q2, while retained earnings surged to $27.5B from $26.7B in 2022Q4, as per balance sheet data, indicating strong profit retention despite dividend payments.

The increase in retained earnings suggests that Haleon is generating sufficient profits to support both dividends and reinvestment, even as it deleverages. However, the equity base is relatively flat, implying that share repurchases and dividends are offsetting earnings accretion. The stability of equity despite debt reduction indicates a balanced capital return policy, but investors should watch for potential dilution from stock-based compensation.

Liquidity Buffer Thin Amid Seasonal Swings

Current ratio dropped to 0.69 in 2026Q2 from 0.92 in 2025Q4, as reported in balance sheet data, with cash at $821M, suggesting a tight liquidity position that may strain during off-peak seasons.

The sub-1.0 current ratio indicates that current liabilities exceed current assets, which is unusual for a consumer staples company and may reflect aggressive working capital management or seasonal inventory build-up. The low cash balance relative to total debt of $8.2B suggests reliance on operating cash flow and credit facilities for short-term obligations. This warrants close monitoring, especially if revenue growth remains negative.

Goodwill Impairment Risk Lurks

Goodwill of $25.6B in 2026Q2, as per balance sheet data, represents a significant portion of total assets, and any brand underperformance could trigger impairments that erode equity.

The large goodwill balance, inherited from the GSK demerger, is a non-cash asset that may not reflect the true economic value of the brands. If the company's growth stalls or regulatory actions (e.g., phenylephrine ruling) impact key products, impairment charges could be substantial, reducing reported equity and potentially affecting debt covenants. Investors should assess the recoverability of these intangibles based on segment cash flows and market conditions.

HLN — Frequently Asked Questions

Quick answers to the most common questions about buying HLN stock.

What are the total assets of Haleon plc (HLN)?

As of 2025, Haleon plc (HLN) had total assets of $32.57B including $4.54B in current assets.

How much debt does Haleon plc (HLN) have?

Haleon plc (HLN) carries total debt of $8.59B, offset by $1.32B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Haleon plc?

Haleon plc (HLN) has total shareholders' equity (book value) of $16.40B ($3.65 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Haleon plc's current ratio and liquidity?

Haleon plc (HLN) reported a current ratio of 0.92x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.